BZ NOTE On Acasti Pharma Price Action: On Nov. 26, 2019, Co. Issued Press Release Highlighting The Last Patient Visit In Its TRILOGY 1 Trial For Hypertriglceridemia Treatment, Said Was On Track For Topline Results In Dec.